| Dr Christopher J Montague, MD | |
|
400 E 3rd St, Duluth, MN 55805-1951 | |
| (218) 786-8364 | |
| Not Available |
| Full Name | Dr Christopher J Montague |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 31 Years |
| Location | 400 E 3rd St, Duluth, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134160104 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Essentia Health St Mary's Medical Center | Duluth, MN | Hospital |
| Essentia Health St Joseph's Medical Center | Brainerd, MN | Hospital |
| Essentia Health Duluth | Duluth, MN | Hospital |
| Essentia Health Virginia | Virginia, MN | Hospital |
| Memorial Medical Center | Ashland, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Duluth Clinic Ltd | 2567374283 | 932 |
News Archive
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today the publication of research from the labs of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and colleagues entitled, "Identification of a Novel Class of HCV Inhibitors". Published in the January 20th edition of Science and Translational Medicine, the research validates a domain, termed 4BAH2, within the non-structural protein (NS4B) of the HCV genome, as essential for HCV replication and describes the development of a high-throughput screen leading to the identification of small molecule inhibitors of 4BAH2.
Biotech company Pharming Group NV ("Pharming" or "the Company") today received confirmation of validation from EMEA of its Marketing Authorization Application (MAA) for Rhucin.
Levodopa is the preferred treatment for Parkinson's disease in the clinic. However, long-term use of levodopa may lead to various motor complications, among which levodopa-induced dyskinesia is the most common, severely affecting patients' quality of life.
When you pass by a stranger in need of help, do you stop to lend a hand? Maybe not... A landmark 1973 study found that seminary students in a hurry were less likely to help someone in distress, even when they were on their way to deliver a talk on the Parable of the Good Samaritan.
› Verified 1 days ago
| Entity Name | The Duluth Clinic Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902563638 PECOS PAC ID: 2567374283 Enrollment ID: O20031103000229 |
News Archive
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today the publication of research from the labs of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and colleagues entitled, "Identification of a Novel Class of HCV Inhibitors". Published in the January 20th edition of Science and Translational Medicine, the research validates a domain, termed 4BAH2, within the non-structural protein (NS4B) of the HCV genome, as essential for HCV replication and describes the development of a high-throughput screen leading to the identification of small molecule inhibitors of 4BAH2.
Biotech company Pharming Group NV ("Pharming" or "the Company") today received confirmation of validation from EMEA of its Marketing Authorization Application (MAA) for Rhucin.
Levodopa is the preferred treatment for Parkinson's disease in the clinic. However, long-term use of levodopa may lead to various motor complications, among which levodopa-induced dyskinesia is the most common, severely affecting patients' quality of life.
When you pass by a stranger in need of help, do you stop to lend a hand? Maybe not... A landmark 1973 study found that seminary students in a hurry were less likely to help someone in distress, even when they were on their way to deliver a talk on the Parable of the Good Samaritan.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher J Montague, MD 400 E 3rd St, Duluth, MN 55805-1951 Ph: (218) 786-8364 | Dr Christopher J Montague, MD 400 E 3rd St, Duluth, MN 55805-1951 Ph: (218) 786-8364 |
News Archive
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today the publication of research from the labs of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and colleagues entitled, "Identification of a Novel Class of HCV Inhibitors". Published in the January 20th edition of Science and Translational Medicine, the research validates a domain, termed 4BAH2, within the non-structural protein (NS4B) of the HCV genome, as essential for HCV replication and describes the development of a high-throughput screen leading to the identification of small molecule inhibitors of 4BAH2.
Biotech company Pharming Group NV ("Pharming" or "the Company") today received confirmation of validation from EMEA of its Marketing Authorization Application (MAA) for Rhucin.
Levodopa is the preferred treatment for Parkinson's disease in the clinic. However, long-term use of levodopa may lead to various motor complications, among which levodopa-induced dyskinesia is the most common, severely affecting patients' quality of life.
When you pass by a stranger in need of help, do you stop to lend a hand? Maybe not... A landmark 1973 study found that seminary students in a hurry were less likely to help someone in distress, even when they were on their way to deliver a talk on the Parable of the Good Samaritan.
› Verified 1 days ago
Steven J Eastep, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 915 E 1st St, Duluth, MN 55805 Phone: 218-249-5208 Fax: 218-726-3007 | |
Thomas Craig Nelson, Pathology Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Benjamin R Koch, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Essentia Health Duluth Clinic, Duluth, MN 55805 Phone: 218-786-4109 | |
Sarah J Lundeen, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 915 E 1st St, Duluth, MN 55805 Phone: 218-249-5208 Fax: 218-726-3007 | |
Maria Katarzyna Beaver, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 400 East Third Street, Essentia Health Duluth Clinic, Duluth, MN 55805 Phone: 218-786-8364 | |
Geoffrey Alan Witrak, Pathology Medicare: Not Enrolled in Medicare Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 |